BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li YW, Yang FC, Lu HQ, Zhang JS. Hepatocellular carcinoma and hepatitis B surface protein. World J Gastroenterol 2016; 22(6): 1943-1952 [PMID: 26877602 DOI: 10.3748/wjg.v22.i6.1943]
URL: https://www.wjgnet.com/1007-9327/full/v22/i6/1943.htm
Number Citing Articles
1
Miao Liu, Lingyao Du, Zhiliang He, Libo Yan, Ying Shi, Jin Shang, Hong Tang. Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and PrognosisBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/1252647
2
Tomohiro Nishikawa, Masahiro Matsui, Saori Onishi, Kosuke Ushiro, Akira Asai, Soo-Ki Kim, Hiroki Nishikawa. Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis BInternational Journal of Molecular Sciences 2024; 25(4): 2245 doi: 10.3390/ijms25042245
3
Liuqing Yang, Qiang Wang, Tingting Cui, Jinxin Huang, Hui Jin, Stefano Gitto. Reporting and Performance of Hepatocellular Carcinoma Risk Prediction Models: Based on TRIPOD Statement and Meta-AnalysisCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/9996358
4
Matthias Buechter, Arne Maria Günther, Paul Manka, Guido Gerken, Alisan Kahraman. Factors Positively Correlated with Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis BJournal of Personalized Medicine 2024; 14(4): 390 doi: 10.3390/jpm14040390
5
Christopher A. Dietz, Heiner Wedemeyer. Rolle der Hepatitis-B-Impfung in der Prävention des hepatozellulären KarzinomsDer Onkologe 2022; 28(1): 15 doi: 10.1007/s00761-021-01036-0
6
Julian Musa, Jing Li, Thomas GP Grünewald. Hepatitis B virus large surface protein is priming for hepatocellular carcinoma development via induction of cytokinesis failureThe Journal of Pathology 2019; 247(1): 6 doi: 10.1002/path.5169
7
Ming Wang, Dong Xi, Qin Ning. Virus-induced hepatocellular carcinoma with special emphasis on HBVHepatology International 2017; 11(2): 171 doi: 10.1007/s12072-016-9779-5
8
Lilian Yan Liang, Vincent Wai-Sun Wong, Hidenori Toyoda, Yee-Kit Tse, Terry Cheuk-Fung Yip, Becky Wing-Yan Yuen, Toshifumi Tada, Takashi Kumada, Hye-Won Lee, Grace Chung-Yan Lui, Henry Lik-Yuen Chan, Grace Lai-Hung Wong. Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patientsJournal of Gastroenterology 2020; 55(9): 899 doi: 10.1007/s00535-020-01700-z
9
Jianhua Li, Wenzhi Guo, Wenping Xue, Pengfei Xu, Zhen Deng, Danhua Zhang, Shouhua Zheng, Xinguang Qiu. Long noncoding RNA AURKAPS1 potentiates malignant hepatocellular carcinoma progression by regulating miR-142, miR-155 and miR-182Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56036-3
10
L.A. Romano, M.da C. Klosterhoff, A.F.F. de Medeiros, S. Oliveira, V.F. Pedrosa. Occurrence of hepatocellular carcinoma in wild pejerrey Odontesthes bonariensis (Teleostei, Atherinidae)Bulletin of the European Association of Fish Pathologists 2022; 41(6) doi: 10.48045/001c.36981
11
Jing-Jing Han, Yu-An Hu, Yuchen Nan, Yu Chen, Yong-Lin Yang. Decreased expression of HBV surface antigen (HBsAg) with sK122R and sV96A co-mutation is associated with an ineffective antibody response in a chronic hepatitis B patientInfection, Genetics and Evolution 2023; 111: 105431 doi: 10.1016/j.meegid.2023.105431
12
Weidong Zhao, Gan Zhao, Shuren Zhang, Xianzheng Wang, Xueping Yu, Bin Wang. Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GM-CSF and IFN-α as an effective therapeutic vaccine adjuvantOncotarget 2018; 9(76): 34213 doi: 10.18632/oncotarget.25789
13
Zainab M.A. Anis, Amira Y. Ahmed, Hanan H. Soliman, Hala M. Nagy. Serum growth differentiation factor 15 levels as a marker for liver cirrhosis and hepatocellular carcinoma on top of liver cirrhosisTanta Medical Journal 2022; 50(4): 251 doi: 10.4103/tmj.tmj_173_20
14
Citrawati Dyah Kencono Wungu, Fis Citra Ariyanto, Gwenny Ichsan Prabowo, Soetjipto Soetjipto, Retno Handajani. Meta‐analysis: Association between hepatitis B virus preS mutation and hepatocellular carcinoma riskJournal of Viral Hepatitis 2021; 28(1): 61 doi: 10.1111/jvh.13402
15
Hai Huang, Wei Zhou, Haiyan Zhu, Pei Zhou, Xunlong Shi. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAsToxicology and Applied Pharmacology 2017; 323: 36 doi: 10.1016/j.taap.2017.03.016
16
Habibollah Mirzaei, Ebrahim Faghihloo. Viruses as key modulators of the TGF‐β pathway; a double‐edged sword involved in cancerReviews in Medical Virology 2018; 28(2) doi: 10.1002/rmv.1967
17
Yan Du, Xue Han, Yi-Bo Ding, Jian-Hua Yin, Guang-Wen Cao. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjectsWorld Journal of Gastroenterology 2016; 22(29): 6565-6572 doi: 10.3748/wjg.v22.i29.6565
18
Atanasio Pandiella-Alonso, Elena Díaz-Rodríguez, Eduardo Sanz. Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive ReviewNutrients 2020; 12(9): 2661 doi: 10.3390/nu12092661
19
Pei-song Bai, Peng Hou, Ying Kong. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathwayExperimental Cell Research 2018; 370(1): 174 doi: 10.1016/j.yexcr.2018.06.020
20
Amanda K. McCullough, R. Stephen Lloyd. Mechanisms underlying aflatoxin-associated mutagenesis – Implications in carcinogenesisDNA Repair 2019; 77: 76 doi: 10.1016/j.dnarep.2019.03.004
21
Huai‐Lung Chang, Wan‐Hsin Wen, Chien‐Nan Lee, Yu‐En Chiu, Chun‐Jen Liu, Mei‐Hwei Chang, Lung‐Huang Lin, Huey‐Ling Chen. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarateJournal of Viral Hepatitis 2022; 29(2): 107 doi: 10.1111/jvh.13628
22
Chun-Chen Wu, Ying-Shan Chen, Liang Cao, Xin-Wen Chen, Meng-Ji Lu. Hepatitis B virus infection: Defective surface antigen expression and pathogenesisWorld Journal of Gastroenterology 2018; 24(31): 3488-3499 doi: 10.3748/wjg.v24.i31.3488
23
Bei Wang, Shengjin Ge, Wanxia Xiong, Zhanggang Xue. Effects of resveratrol pretreatment on endoplasmic reticulum stress and cognitive function after surgery in aged miceBMC Anesthesiology 2018; 18(1) doi: 10.1186/s12871-018-0606-5
24
Yuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Shuya Matsuda, Masaru Muraoka, Natsuko Nakakuki, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Taisuke Inoue, Tadashi Sato, Minoru Sakamoto, Atsuya Yamashita, Kohji Moriishi, Nobuyuki Enomoto, Jason Blackard. HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markersPLOS ONE 2019; 14(2): e0212559 doi: 10.1371/journal.pone.0212559
25
Elham Shirvani-Dastgerdi, Robert E Schwartz, Alexander Ploss. Hepatocarcinogenesis associated with hepatitis B, delta and C virusesCurrent Opinion in Virology 2016; 20: 1 doi: 10.1016/j.coviro.2016.07.009
26
Shahrzad Shoraka, Seyed Mahdi Hosseinian, Ayda Hasibi, Amir Ghaemi, Seyed Reza Mohebbi. The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathwaysFrontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1213145
27
Kirstine Overgaard Nielsen, Aashiq Hussain Mirza, Simranjeet Kaur, Kari Stougaard Jacobsen, Thilde Nordmann Winther, Dieter Glebe, Flemming Pociot, Birthe Hogh, Joachim Størling. Hepatitis B virus suppresses the secretion of insulin-like growth factor binding protein 1 to facilitate anti-apoptotic IGF-1 effects in HepG2 cellsExperimental Cell Research 2018; 370(2): 399 doi: 10.1016/j.yexcr.2018.07.002
28
Rajiv Kumar Mondal, Mousumi Khatun, Priyanka Banerjee, Alip Ghosh, Sumanta Sarkar, Amal Santra, Kausik Das, Abhijit Chowdhury, Soma Banerjee, Simanti Datta. Synergistic impact of mutations in Hepatitis B Virus genome contribute to its occult phenotype in chronic Hepatitis C Virus carriersScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09965-w
29
Seyed Y. Hosseini, Neda Sanaei, Mohamad-Reza Fattahi, Seyed A. Malek-Hosseini, Jamal Sarvari. Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patientsAnnals of Hepatology 2019; 18(4): 640 doi: 10.1016/j.aohep.2018.12.006
30
Tengyue Hu, Jiayi Wang, Weixiu Li, Miao Liu, Ning Han, Man Yuan, Lingyao Du, Hong Tang. Endoplasmic Reticulum Stress in Hepatitis B Virus and Hepatitis C Virus InfectionViruses 2022; 14(12): 2630 doi: 10.3390/v14122630
31
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis BreakdownFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
32
Na Qiu, Akshaya Srikanth, Medhanie Mulaw, Umesh Tharehalli, Shanthiya Selvachandran, Martin Wagner, Thomas Seufferlein, Katja Stifter, André Lechel, Reinhold Schirmbeck. CD8 T cell-mediated depletion of HBV surface-antigen-expressing, bilineal-differentiated liver carcinoma cells generates highly aggressive escape variantsOncoImmunology 2023; 12(1) doi: 10.1080/2162402X.2023.2215096
33
Yaming Liu, Jessica L. Maiers, Yajuan Rui, Xiaoming Jiang, Bayasi Guleng, Jianlin Ren. Apolipoprotein H drives hepatitis B surface antigen retention and endoplasmic reticulum stress during hepatitis B virus infectionThe International Journal of Biochemistry & Cell Biology 2021; 131: 105906 doi: 10.1016/j.biocel.2020.105906
34
Guannan Wang, Xiaosan Fang, Meng Han, Xiaoming Wang, Qiang Huang. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2International Journal of Molecular Medicine 2018;  doi: 10.3892/ijmm.2018.3358
35
Jing Tang, Li-Juan Zhang, Min Kang, Rong Huang, Hui-Ye Shu, Hong Wei, Jie Zou, Yi-Cong Pan, Qian Ling, Yi Shao. AFP and CA-125 as an accurate risk factor to predict eye metastasis in hypertension patients with liver carcinoma: A STROBE-compliant articleFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1010903
36
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and PathogenesisJournal of Clinical Medicine 2017; 6(12): 111 doi: 10.3390/jcm6120111
37
Yuno Nishida, Michio Imamura, Yuji Teraoka, Kei Morio, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, Tomokazu Kawaoka, Daiki Miki, Masataka Tsuge, Akira Hiramatsu, Hiromi Abe‐Chayama, C. Nelson Hayes, Hiroshi Aikata, Noriko Sasaki, Tomomi Sekiguchi, Hideki Kinukawa, Toru Yoshimura, Kazuaki Chayama. Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patientsJournal of Viral Hepatitis 2021; 28(9): 1304 doi: 10.1111/jvh.13557
38
Haiyan Li, Fuchu Qian, Weihua Zou, Fang Jin, Dongli Li, Yaqin Zhang. Seroprevalence and mutations in the major hydrophilic region of hepatitis B virus among pregnant women in Huzhou, ChinaTransactions of The Royal Society of Tropical Medicine and Hygiene 2022; 116(9): 874 doi: 10.1093/trstmh/trac040
39
Feilin Ge, Yan Yang, Zhaofang Bai, Lanlan Si, Xuemei Wang, Jia Yu, Xiaohe Xiao, Yan Liu, Zhigang Ren. The role of Traditional Chinese medicine in anti-HBV: background, progress, and challengesChinese Medicine 2023; 18(1) doi: 10.1186/s13020-023-00861-2
40
Wai Yeow Lee, Maulana Bachtiar, Cheryl C. S. Choo, Caroline G. Lee. Comprehensive review of Hepatitis B Virus‐associated hepatocellular carcinoma research through text mining and big data analyticsBiological Reviews 2019; 94(2): 353 doi: 10.1111/brv.12457
41
Natalia Freitas, Tetyana Lukash, Sumedha Gunewardena, Benjamin Chappell, Betty L. Slagle, Severin O. Gudima, Rozanne M. Sandri-Goldin. Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus CarriersJournal of Virology 2018; 92(10) doi: 10.1128/JVI.02221-17
42
Wenqi Song, Xuemei Zhang, Lin Feng, Yongwei Lai, Tongtong Li, Pengxia Zhang. Downregulated lncRNA SNHG18 Suppresses the Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma and Meditates the Antitumor Effect of Oleanolic AcidCancer Management and Research 2022; : 687 doi: 10.2147/CMAR.S346920
43
Dowluru S.V.G.K. Kaladhar, Tantravahi Srinivasan. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 257 doi: 10.1016/B978-0-323-98806-3.00005-2